Point of Care Molecular Diagnostics Market

Point of Care Molecular Diagnostics Market Size By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Others), By Technology (PCR, Genetic Sequencing, Hybridization, and Microarray), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13689
  • Published Date: Sep, 2023
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global point of care molecular diagnostics market was valued at USD 8 billion in 2022, growing at a CAGR of 10.8% from 2023 to 2032. The market is expected to reach USD 22.3 billion by 2032. Rising demand for rapid testing and a large number of new product launches for point-of-care tests are expected to fuel the growth of the point-of-care molecular diagnostics market in the forecast period. Furthermore, one of the essential causes for market expansion is constant improvement in the quality of items available on the shelf.

Market Introduction:

Point-of-Care (POC) molecular diagnostics are tests performed close to the patient. It can be done at a hospital, ambulance, clinic, field, or doctor's office. POC molecular diagnostics is quick and efficient, allowing it to reach more patients. The test findings are quick, ensuring that patients receive prompt therapy. It also removes the patient's follow-up visits. Molecular technologies examine the patient's nucleic acid and DNA for pathogens, infections, tumours, or anomalies. These tests look for specific DNA or RNA sequences linked to disorders, such as single nucleotide polymorphism (SNP), insertions, rearrangements, deletions, and others. Oncology, human leukocyte antigen typing, pharmacogenomics, infectious illnesses, genetic disease screening, and coagulation are a few of molecular diagnostics' therapeutic uses. Each molecular analysis requires three basic steps: extraction and purification of nucleic acid, amplification or making copies of the nucleic acid of interest (target), or attaching multiple copies of a dye to a single target copy, and detection of the amplified target using real-time polymerase chain reaction (PCR) or end product detection including microarrays, Luminex, i.e. siRNA.

Point of Care Molecular Diagnostics Market Size

Get an overview of this study by requesting a free sample

Recent Development

In December 2021, FIND invested USD 21 million in Biomeme, Bioneer, Qlife, and S.D. Biosensor to speed the research, manufacturing, and deployment of low-cost point-of-care molecular diagnostic platforms capable of detecting various pathogens that cause disease, including COVID-19.

In January 2022, Roche will launch its Cobas Pulse System in certain countries that accept the CE Mark. Roche Diagnostics' latest generation of integrated point-of-care solutions for professional blood glucose management.

In October 2021, Thermo Fisher Scientific announced that it had received FDA Emergency Use Authorization (EUA) to run COVID-19 tests with the Spectrum Solutions Spectrum DNA SDNA-1000 collection device, a high-throughput, automated COVID-19 testing system on the Amplitude Solution that employs a new saliva sample collection method.

Market Dynamics:
Drivers

Rise of Chronic Disease- Chronic diseases and acute infections are on the rise in developing countries, owing to, among other things, a lack of health knowledge, inadequate medical infrastructure, and a sedentary lifestyle. As a result of these factors, diagnosis and treatment are delayed, as is the quality of care. The need for point-of-care tests for rapid diagnosis is increasing because of its ease of use, low cost, and small product size.

Restraints:

Growing Awareness of Health Issues- The market's expansion has been impeded by higher levels of education and growing awareness of health issues associated with tobacco use, such as various cancers, cardiovascular disorders, pulmonary ailments, etc. In addition, stringent laws in wealthy nations further impede market expansion.

Opportunities:

Launching New Products- Launching novel products will boost the industry's growth by allowing for rapid advancement in the research and development (R&D) of point-of-care testing (POCT) diagnostic instruments. Furthermore, advancements in component materials, reader technologies, reagents, and sensitivities have made quantitative results using lateral flow assay more attainable, boosting market expansion.

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global point of care molecular diagnostics market, with a 55% market revenue share in 2022.

The presence of a growing senior population base and increased healthcare expenditure levels are two significant factors contributing to its highest proportion. Furthermore, increased government backing and funding for COVID-19-related items are expected to lay the groundwork for a regional market. The Departments of Health and Human Services and Defence granted more than USD 562 million to a dozen U.S. companies in October 2021 to fund the fabrication of COVID-19 tests and associated supplies.

In February 2022, Sense Biodetection signed a strategic partnership with Una Health (Una) to distribute the Veros COVID-19 test in the United Kingdom.

North America Region Point of Care Molecular Diagnostics Market Share in 2022 - 55%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Application Segment Analysis

The application segment is divided into infectious diseases, oncology, hematology, prenatal testing, endocrinology, and others. The oncology segment dominated the market, with a market share of around 35% in 2022. Key market players focus on new product launches and collaborations to preserve their market position. Inex Innovate, for example, announced C.E. clearance of their point-of-care OvaCis Rapid Test in May 2022. This test can tell you whether your ovarian cysts are benign or cancerous. This test produces results in 15 minutes and has significantly reduced test duration. Many pipeline projects are expected to join the market in the following years, supporting the expansion of the oncology segment. Capsulomics, for example, stated in March 2022 that they will be releasing two PCR-based epigenetic assays for esophageal cancer.

Technology Segment Analysis

The technology segment is divided into PCR, genetic sequencing, hybridization, and microarray. The PCR segment dominated the market, with a market share of around 40% in 2022. The availability of multiple RT-PCR and dPCR techniques is projected to fuel segment expansion in the coming years. The use of this amplification technology in respiratory illnesses and HIV has expanded significantly, and firms in this market are adopting the trend of updating platforms and cartridges based on consumer expectations to give convenience to testing.

Some of the Key Market Players:
  • Abbott
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Nova Biomedical
  • QIAGEN
  • Nipro Diagnostics
  • Danaher
  • Bio-Rad Laboratories, Inc.
  • bioMérieux
  • Agilent Technologies, Inc.
  • Abaxis
  • OraSure Technologies

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 8 Billion
Market size value in 2032 USD 22.3 Billion
CAGR (2023 to 2032) 10.8%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Application, Technology

Frequesntly Asked Questions

As per The Brainy Insights, the size of the point of care molecular diagnostics market was valued at USD 8 billion in 2022 to USD 22.3 billion by 2032.

The global point of care molecular diagnostics market is growing at a CAGR of 10.8% during the forecast period 2023-2032.

North America emerged as the largest point of care molecular diagnostics market.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Application
          4.3.2. Market Attractiveness Analysis by Technology
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Rise of chronic disease
    5.3. Restraints
          5.3.1. Growing awareness of health issues
    5.4. Opportunities
          5.4.1. Launching new products
    5.5. Challenges
          5.5.1. Inadequate reimbursements

6. Global Point of Care Molecular Diagnostics Market Analysis and Forecast, By Application
    6.1. Segment Overview
    6.2. Infectious Diseases
    6.3. Oncology
    6.4. Hematology
    6.5. Prenatal Testing
    6.6. Endocrinology
    6.7. Others

7. Global Point of Care Molecular Diagnostics Market Analysis and Forecast, By Technology
    7.1. Segment Overview
    7.2. PCR
    7.3. Genetic Sequencing
    7.4. Hybridization
    7.5. Microarray

8. Global Point of Care Molecular Diagnostics Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Point of Care Molecular Diagnostics Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in Global Point of Care Molecular Diagnostics Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. Abbott
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Bayer AG
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. F. Hoffmann-La Roche AG
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Nova Biomedical
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. QIAGEN
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Nipro Diagnostics
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Danaher
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Bio-Rad Laboratories, Inc.
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. BioMérieux
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Agilent Technologies, Inc.
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
    10.11. Abaxis
          10.11.1. Business Overview
          10.11.2. Company Snapshot
          10.11.3. Company Market Share Analysis
          10.11.4. Company Product Portfolio
          10.11.5. Recent Developments
          10.11.6. SWOT Analysis
    10.12. OraSure Technologies
          10.12.1. Business Overview
          10.12.2. Company Snapshot
          10.12.3. Company Market Share Analysis
          10.12.4. Company Product Portfolio
          10.12.5. Recent Developments
          10.12.6. SWOT Analysis
 

List of Table

1. Global Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

2. Global Infectious Diseases, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion) 

3. Global Oncology, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion) 

4. Global Hematology, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion) 

5. Global Prenatal Testing, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion) 

6. Global Endocrinology, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion) 

7. Global Others, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion) 

8. Global Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

9. Global PCR, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion)

10. Global Genetic Sequencing, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion)

11. Global Hybridization, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion)

12. Global Microarray, Point of Care Molecular Diagnostics Market, By Region, 2019-2032 (USD Billion)

13. North America Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

14. North America Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

15. U.S. Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

16. U.S. Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

17. Canada Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

18. Canada Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

19. Mexico Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

20. Mexico Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

21. Europe Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

22. Europe Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

23. Germany Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

24. Germany Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

25. France Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

26. France Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

27. U.K. Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

28. U.K. Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

29. Italy Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

30. Italy Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

31. Spain Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

32. Spain Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

33. Asia Pacific Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

34. Asia Pacific Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

35. Japan Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

36. Japan Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

37. China Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

38. China Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

39. India Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

40. India Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

41. South America Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

42. South America Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

43. Brazil Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

44. Brazil Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

45. Middle East and Africa Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

46. Middle East and Africa Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

47. UAE Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

48. UAE Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

49. South Africa Point of Care Molecular Diagnostics Market, By Application, 2019-2032 (USD Billion)

50. South Africa Point of Care Molecular Diagnostics Market, By Technology, 2019-2032 (USD Billion)

List of Figures 

1. Global Point of Care Molecular Diagnostics Market Segmentation

2. Global Point of Care Molecular Diagnostics Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Point of Care Molecular Diagnostics Market Attractiveness Analysis by Application

9. Global Point of Care Molecular Diagnostics Market Attractiveness Analysis by Technology

10. Global Point of Care Molecular Diagnostics Market Attractiveness Analysis by Region

11. Global Point of Care Molecular Diagnostics Market: Dynamics

12. Global Point of Care Molecular Diagnostics Market Share by Application (2023 & 2032)

13. Global Point of Care Molecular Diagnostics Market Share by Technology (2023 & 2032)

14. Global Point of Care Molecular Diagnostics Market Share by Regions (2023 & 2032)

15. Global Point of Care Molecular Diagnostics Market Share by Company (2022)

This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global point of care molecular diagnostics market based on the below-mentioned segments:

Global Point of Care Molecular Diagnostics Market By Application:

  • Infectious Diseases
  • Oncology
  • Hematology
  • Prenatal Testing
  • Endocrinology
  • Others

Global Point of Care Molecular Diagnostics Market By Technology:

  • PCR
  • Genetic Sequencing
  • Hybridization
  • Microarray

Global Point of Care Molecular Diagnostics Market By Region:  

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date